Yinxue Yang
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Genomics, phytochemicals, and oxidative stress 4
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 3
- Oncology 8
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Hong Zhe (2 shared papers)Shu-Feng Zhou (1 shared paper)Yanyang Wang (1 shared paper)Zhixu He (1 shared paper)Xiaoming Liu (6 shared papers)Yong Du (6 shared papers)William C. Cho (5 shared papers)Xueji Zhang (8 shared papers)
- Journals
- Drug Design Development and Therapy (6 papers)Clinical and Experimental Pharmacology and Physiology (2 papers)Chemico-Biological Interactions (2 papers)Medical Oncology (2 papers)Oncology Reports (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yinxue Yang
43 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 97
- Toxicology 88
- Cancer Research 327
- Molecular Biology 822
- Geriatrics and Gerontology 29
- Oncology 223
Countries citing papers authored by Yinxue Yang
This map shows the geographic impact of Yinxue Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinxue Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinxue Yang more than expected).
Fields of papers citing papers by Yinxue Yang
This network shows the impact of papers produced by Yinxue Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinxue Yang. The network helps show where Yinxue Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yinxue Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 210 | |
| 2 | 2013 | 131 | |
| 3 | 2017 | 78 | |
| 4 | 2015 | 65 | |
| 5 | 2014 | 63 | |
| 6 | 2015 | 57 | |
| 7 | 2011 | 55 | |
| 8 | 2011 | 53 | |
| 9 | Bardoxolone methyl (CDDO-Me or RTA402) induces cell cycle arrest, apoptosis and autophagy via PI3K/Akt/mTOR and p38 MAPK/Erk1/2 signaling pathways in K562 cells. | 2017 | 48 |
| 10 | 2016 | 46 | |
| 11 | 2011 | 40 | |
| 12 | 2015 | 38 | |
| 13 | 2015 | 36 | |
| 14 | 2013 | 35 | |
| 15 | 2016 | 35 | |
| 16 | 2016 | 32 | |
| 17 | 2016 | 30 | |
| 18 | 2011 | 30 | |
| 19 | 2012 | 28 | |
| 20 | 2010 | 27 |
About Yinxue Yang
Yinxue Yang is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Cell Biology, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers), RNA modifications and cancer (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Toxicology (88 citations), Cancer Research (327 citations), Molecular Biology (822 citations), Geriatrics and Gerontology (29 citations) and Oncology (223 citations). Yinxue Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hong Zhe, Shu-Feng Zhou, Yanyang Wang, Zhixu He, Xiaoming Liu, Yong Du, William C. Cho, Xueji Zhang, Tianxin Yang and Zhixu He. Their work appears in journals such as Drug Design Development and Therapy, Clinical and Experimental Pharmacology and Physiology, Chemico-Biological Interactions, Medical Oncology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.